Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Nature Communications|June 24, 2015
A mosquito lipoxin/lipocalin complex mediates innate immune priming in Anopheles gambiaeJose Luis Ramirez, Giselle de Almeida Oliveira, Eric Calvo, et al.
Circulation Research|December 13, 2019
Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled StudyPatricia R Souza, Raquel M Marques, Esteban A Gomez, et al.
Infection and Immunity|December 16, 2015
Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis LeukocytesChin-Wei Wang, Romain A Colas, Jesmond Dalli, et al.
Critical Care Medicine|September 16, 2016
Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical OutcomesJesmond Dalli, Romain A Colas, Carolina Quintana, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 18, 2019
Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cellsMinna Holopainen, Romain A Colas, Sami Valkonen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2022
Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunitApril S Caravaca, Alessandro L Gallina, Laura Tarnawski, et al.
Pain|May 8, 2020
Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritisBenjamin L Allen, Karli Montague-Cardoso, Raffaele Simeoli, et al.
JCI Insight|March 23, 2018
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammationMadhur P Motwani, Romain A Colas, Marc J George, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2017
Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protectionThomas Gobbetti, Jesmond Dalli, Romain A Colas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 2, 2017
Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver DiseaseLouise China, Alexander Maini, Simon S Skene, et al.
Pageof 8